Management of Fracture Risk in Patients with Chronic Obstructive Pulmonary Disease (COPD): Building a UK Consensus Through Healthcare Professional and Patient Engagement

References

• CoughlanT, DockeryF. Osteoporosis and fracture risk in older people. Clin Med (Lond). 2014;14(2):187–191. doi:10.7861/clinmedicine.14-2-18724715132
   PubMed Web of Science ®Google Scholar
• RouxC, WymanA, HoovenFH, et al. Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int. 2012;23(12):2863–2871. doi:10.1007/s00198-012-1935-822398855
   PubMed Web of Science ®Google Scholar
• SvedbomA, HernlundE, IvergardM, et al. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8:137. doi:10.1007/s11657-013-0137-024113838
   PubMed Web of Science ®Google Scholar
• BurgeRT, WorleyD, JohansenA, BhattacharyyaS, BoseU. The cost of osteoporotic fractures in the UK: projections for 2000–2020. J Med Econ. 2001;4(1–4):51–62. doi:10.3111/200104051062
   Google Scholar
• van StaaTP, DennisonEM, LeufkensHG, CooperC. Epidemiology of fractures in England and Wales. Bone. 2001;29(6):517–522. doi:10.1016/S8756-3282(01)00614-711728921
   PubMed Web of Science ®Google Scholar
• GuptaA, GreeningNJ, EvansRA, SamuelsA, TomsN, SteinerMC. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease. Chron Respir Dis. 2019;16:1479972318769763. doi:10.1177/147997231876976329661041
   PubMed Web of Science ®Google Scholar
• BoltonCE, IonescuAA, ShielsKM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(12):1286–1293. doi:10.1164/rccm.200406-754OC15374843
   PubMed Web of Science ®Google Scholar
• SabitR, BoltonCE, EdwardsPH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(12):1259–1265. doi:10.1164/rccm.200701-067OC17363772
   PubMed Web of Science ®Google Scholar
• DuckersJM, EvansBA, FraserWD, StoneMD, BoltonCE, ShaleDJ. Low bone mineral density in men with chronic obstructive pulmonary disease. Respir Res. 2011;12:101. doi:10.1186/1465-9921-12-10121812978
   PubMed Web of Science ®Google Scholar
• Graat-VerboomL, WoutersEF, SmeenkFW, van den BorneBE, LundeR, SpruitMA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J. 2009;34(1):209–218. doi:10.1183/09031936.5013040819567604
   PubMed Web of Science ®Google Scholar
• HakamyA, BoltonCE, GibsonJE, McKeeverTM. Risk of fall in patients with COPD. Thorax. 2018;73(11):1079–1080. doi:10.1136/thoraxjnl-2017-21100829563161
   PubMed Web of Science ®Google Scholar
• BeauchampMK, HillK, GoldsteinRS, Janaudis-FerreiraT, BrooksD. Impairments in balance discriminate fallers from non-fallers in COPD. Respir Med. 2009;103(12):1885–1891. doi:10.1016/j.rmed.2009.06.00819592229
   PubMed Web of Science ®Google Scholar
• SeymourJM, SpruitMA, HopkinsonNS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36(1):81–88. doi:10.1183/09031936.0010490919897554
   PubMed Web of Science ®Google Scholar
• DoddJW, GetovSV, JonesPW. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–922. doi:10.1183/09031936.0012510920356988
   PubMed Web of Science ®Google Scholar
• AkyeaRK, McKeeverTM, GibsonJ, ScullionJE, BoltonCE. Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study. BMJ Open. 2019;9(4):e024951. doi:10.1136/bmjopen-2018-024951
   PubMed Web of Science ®Google Scholar
• ReganEA, RadcliffTA, HendersonWG, et al. Improving hip fractures outcomes for COPD patients. COPD. 2013;10(1):11–19. doi:10.3109/15412555.2012.72307223272668
   PubMedGoogle Scholar
• BussL, McKeeverT, NightingaleJ, et al. Hip fracture outcomes in patients with chronic obstructive pulmonary disease. Br J Anaesth. 2018;121(6):1377–1379. doi:10.1016/j.bja.2018.09.00830442271
   PubMed Web of Science ®Google Scholar
• SarkarM, BhardwajR, MadabhaviI, KhatanaJ. Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med. 2015;9:CCRPM. S22803.
   PubMedGoogle Scholar
• British Lung Foundation. Chronic obstructive pulmonary disease (COPD) statistics; 2019 Available from: https://statistics.blf.org.uk/copd. Accessed 429, 2020.
   Google Scholar
• National Institute of Clinical Excellence. NICE (CG146) Osteoporosis: Assessing the Risk of Fragility Fracture; 2012 Amended in 2017.
   Google Scholar
• National Institute of Clinical Excellence. Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care; 2010.
   Google Scholar
• National Institute of Clinical Excellence. NICE (NG115) Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management; 2018.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD (2019 Report); 2019:130–134
   Google Scholar
• SilvermanD. Interpreting Qualitative Data. Sage; 2015.
   Google Scholar
• SilvaDR, CoelhoAC, DumkeA, et al. Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study. Respir Care. 2011;56(7):961–968. doi:10.4187/respcare.0105621352667
   PubMed Web of Science ®Google Scholar
• McEvoyCE, EnsrudKE, BenderE, et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(3 Pt 1):704–709. doi:10.1164/ajrccm.157.3.97030809517579
   PubMed Web of Science ®Google Scholar
• ShaneE, SilverbergSJ, DonovanD, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med. 1996;101(3):262–269. doi:10.1016/S0002-9343(96)00155-68873487
   PubMed Web of Science ®Google Scholar
• SinDD, ManJP, ManSF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003;114(1):10–14. doi:10.1016/S0002-9343(02)01297-412543283
   PubMed Web of Science ®Google Scholar
• JorgensenNR, SchwarzP, HolmeI, HenriksenBM, PetersenLJ, BackerV. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med. 2007;101(1):177–185. doi:10.1016/j.rmed.2006.03.02916677808
   PubMed Web of Science ®Google Scholar
• MillerJ, EdwardsLD, AgustiA, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107(9):1376–1384. doi:10.1016/j.rmed.2013.05.00123791463
   PubMed Web of Science ®Google Scholar
• FergusonGT, CalverleyPMA, AndersonJA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD health study. Chest. 2009;136(6):1456–1465. doi:10.1378/chest.08-301619581353
   PubMed Web of Science ®Google Scholar
• Graat-VerboomL, SmeenkFW, van den BorneBE, et al. Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: a case control study. Bone. 2012;50(6):1234–1239. doi:10.1016/j.bone.2012.02.63822426499
   PubMed Web of Science ®Google Scholar
• JaramilloJD, WilsonC, StinsonDS, et al. Reduced bone density and vertebral fractures in smokers. Men and COPD Patients at increased risk. Ann Am Thorac Soc. 2015;12(5):648–656. doi:10.1513/AnnalsATS.201412-591OC25719895
   PubMed Web of Science ®Google Scholar
• GreulichT, WeistBJD, KoczullaAR, et al. Prevalence of comorbidities in COPD patients by disease severity in a German population. Respir Med. 2017;132:132–138. doi:10.1016/j.rmed.2017.10.00729229085
   PubMed Web of Science ®Google Scholar
• LekamwasamS, AdachiJD, AgnusdeiD, et al. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int. 2012;23(9):2257–2276. doi:10.1007/s00198-012-1958-122434203
   PubMed Web of Science ®Google Scholar
• LekamwasamS, AdachiJD, AgnusdeiD, et al. An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. Arch Osteoporos. 2012;7:25–30. doi:10.1007/s11657-012-0070-723225278
   PubMedGoogle Scholar
• JanovskaZ. Bisphosphonate-related osteonecrosis of the jaws. A severe side effect of bisphosphonate therapy. Acta Medica (Hradec Kralove). 2012;55(3):111–115. doi:10.14712/18059694.2015.4723297518
   PubMedGoogle Scholar
• AndradeSE, MajumdarSR, ChanKA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003;163(17):2052–2057. doi:10.1001/archinte.163.17.205214504118
   PubMed Web of Science ®Google Scholar
• FreedmanKB, KaplanFS, BilkerWB, StromBL, LoweRA. Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am. 2000;82-a(8):1063–1070. doi:10.2106/00004623-200008000-00001
   Web of Science ®Google Scholar
• GongHS, OhWS, ChungMS, OhJH, LeeYH, BaekGH. Patients with wrist fractures are less likely to be evaluated and managed for osteoporosis. J Bone Joint Surg Am. 2009;91(10):2376–2380. doi:10.2106/JBJS.H.0187119797572
   PubMed Web of Science ®Google Scholar
• CompstonJ, CooperA, CooperC, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12(1):43. doi:10.1007/s11657-017-0324-528425085
   PubMed Web of Science ®Google Scholar
• FogelmanY, GoldshteinI, SegalE, Ish-ShalomS. Managing osteoporosis: a survey of knowledge, attitudes and practices among primary care physicians in Israel. PLoS One. 2016;11(8):e0160661. doi:10.1371/journal.pone.016066127494284
   PubMed Web of Science ®Google Scholar
• NeunerJM, SchapiraMM. The importance of physicians’ risk perception in osteoporosis treatment decision making. J Clin Densitom. 2012;15(1):49–54. doi:10.1016/j.jocd.2011.07.00822075328
   PubMed Web of Science ®Google Scholar
• ChenotR, Scheidt-NaveC, GablerS, KochenM, HimmelW. German primary care doctors’ awareness of osteoporosis and knowledge of national guidelines. Exp Clin Endocrinol Diabetes. 2007;115(09):584–589. doi:10.1055/s-2007-98145417943692
   PubMed Web of Science ®Google Scholar
• KanisJ, JohnellO, De LaetC, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375–382. doi:10.1016/j.bone.2004.03.02415268886
   PubMed Web of Science ®Google Scholar
• CurtisEM, van der VeldeR, MoonRJ, et al. Epidemiology of fractures in the United Kingdom 1988–2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone. 2016;87:19–26. doi:10.1016/j.bone.2016.03.00626968752
   PubMed Web of Science ®Google Scholar
• Van StaaT, LeufkensH, AbenhaimL, ZhangB, CooperC. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology. 2000;39(12):1383–1389. doi:10.1093/rheumatology/39.12.138311136882
   PubMed Web of Science ®Google Scholar
• OkazakiR. COPD and bone. Clin Calcium. 2016;26(8):1195–1200.27461504
   PubMedGoogle Scholar
• CrisafulliE, GorgoneP, VagagginiB, et al. Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J. 2010;36(5):1042–1048. doi:10.1183/09031936.0020380920413540
   PubMed Web of Science ®Google Scholar
• KanisJA. FRAX^® Fracture Risk Assessment Tool - University of Sheffield, 2008.
   Google Scholar
• ClinRisk. Qfracture^®-2016 Risk Calculator; 2016.
   Google Scholar
• FørliL, HalseJ, HaugE, et al. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med. 2004;256(1):56–62. doi:10.1111/j.1365-2796.2004.01337.x15189366
   PubMed Web of Science ®Google Scholar
• LehouckA, BoonenS, DecramerM, JanssensW. COPD, bone metabolism, and osteoporosis. Chest. 2011;139(3):648–657. doi:10.1378/chest.10-142721362651
   PubMed Web of Science ®Google Scholar
• RommeEA, GeusensP, LemsWF, et al. Fracture prevention in COPD patients; a clinical 5-step approach. Respir Res. 2015;16:32. doi:10.1186/s12931-015-0192-825848824
   PubMed Web of Science ®Google Scholar
• MazokopakisEE, StarakisIK. Recommendations for diagnosis and management of osteoporosis in COPD men. ISRN Rheumatol. 2011;2011:901416. doi:10.5402/2011/90141622389805
   PubMedGoogle Scholar
• PapaioannouA, ParkinsonW, FerkoN, et al. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int. 2003;14(11):913–917. doi:10.1007/s00198-003-1449-514551675
   PubMed Web of Science ®Google Scholar
• BlackDM, CummingsSR, KarpfDB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348(9041):1535–1541. doi:10.1016/S0140-6736(96)07088-28950879
   PubMed Web of Science ®Google Scholar
• DelmasP, ReckerRR, ChesnutC, et al. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int. 2004;15(10):792–798. doi:10.1007/s00198-004-1602-915071723
   PubMed Web of Science ®Google Scholar
• OrwollE, EttingerM, WeissS, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343(9):604–610. doi:10.1056/NEJM20000831343090210979796
   PubMed Web of Science ®Google Scholar
• SmithB, LaslettL, PileK, et al. Randomized controlled trial of alendronate in airways disease and low bone mineral density. Chron Respir Dis. 2004;1(3):131–137. doi:10.1191/1479972304cd025oa16281654
   PubMedGoogle Scholar
• IngebrigtsenTS, MarottJL, VestboJ, NordestgaardBG, HallasJ, LangeP. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease. Respirology (Carlton, Vic). 2015;20(1):101–107. doi:10.1111/resp.12420
   PubMed Web of Science ®Google Scholar
• AnzuetoA. Impact of exacerbations on COPD. Eur Respir Rev. 2010;19(116):113–118. doi:10.1183/09059180.0000261020956179
   PubMedGoogle Scholar
• CarmelAS, ShiehA, BangH, BockmanRS. The 25(OH)D level needed to maintain a favorable bisphosphonate response is >/=33 ng/mL. Osteoporos Int. 2012;23(10):2479–2487. doi:10.1007/s00198-011-1868-722237813
   PubMed Web of Science ®Google Scholar
• BaroneA, GiustiA, PioliG, et al. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. J Am Geriatr Soc. 2007;55(5):752–757. doi:10.1111/j.1532-5415.2007.01161.x17493196
   PubMed Web of Science ®Google Scholar
• KanisJA, JohnellO, OdénA, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16(2):155–162. doi:10.1007/s00198-004-1640-315175845
   PubMed Web of Science ®Google Scholar
• LawM, HackshawA. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315(7112):841–846. doi:10.1136/bmj.315.7112.8419353503
   PubMed Web of Science ®Google Scholar
• GillespieLD, RobertsonMC, GillespieWJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;9.
   Google Scholar
• MitchellMJ, BazMA, FultonMN, LisorCF, BraithRW. Resistance training prevents vertebral osteoporosis in lung transplant recipients. Transplantation. 2003;76(3):557–562. doi:10.1097/01.TP.0000076471.25132.5212923444
   PubMed Web of Science ®Google Scholar
• ParkK-S, YooJ-I, KimH-Y, JangS, ParkY, HaY-C. Education and exercise program improves osteoporosis knowledge and changes calcium and vitamin D dietary intake in community dwelling elderly. BMC Public Health. 2017;17(1):966. doi:10.1186/s12889-017-4966-429258608
   PubMed Web of Science ®Google Scholar